B. Braun Melsungen AG-製薬・医療分野:企業M&A・提携分析

◆英語タイトル:B. Braun Melsungen AG - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA8010856
◆発行会社(調査会社):GlobalData
◆発行日:2017年12月20日
◆ページ数:43
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:ドイツ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single UserUSD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
B. Braun Melsungen AG (B. Braun) is a global health care company. It offers products and solutions for therapy fields and applications including acute dialysis, infusion therapy, apheresis, interventional vascular, diagnostics and treatment, cardio-thoracic surgery, laparoscopy, degenerative spine surgery, neurosurgery, diabetes, nutrition therapy, general open surgery, orthopedic joint replacement, hemodialysis, pain therapy, incontinence, stoma, infection prevention, and wound management. It has manufacturing facilities and R&D centers in the US, Europe and Asia. The company sells its products through a network of subsidiaries and associated companies in Europe, the Americas, Asia-Pacific, Africa and the Middle East. B. Braun is headquartered in Melsungen, Germany.

B. Braun Melsungen AG – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
B. Braun Melsungen AG, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
B. Braun Melsungen AG, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
B. Braun Melsungen AG, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
B. Braun Melsungen AG, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 8
B. Braun Melsungen AG, Medical Devices Deals, 2011 to YTD 2017 9
B. Braun Melsungen AG, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 10
B. Braun Melsungen AG, Pharmaceuticals & Healthcare, Deal Details 11
Partnerships 11
B. Braun Enters into Parntership with Royal Philip 11
Proxy Biomedical Extends Distribution Agreement with B. Braun Surgical 12
Kinetic Concepts Enters into Co-Marketing Agreement with B. Braun Medical for Prontosan 13
Yungjin Enters Into Distribution Agreement With B. Braun For Enteral Nutrition Products 14
Acquisition 15
B. Braun Medical Acquires Dismed Pharma and Dismed Criticare 15
B. Braun Medical Acquires Carenalis 16
B. Braun Avitum Acquires 51% Stake in Dialy Ser 17
B. Braun Melsungen Completes Acquisition Of Additional 3.02% Stake In Rhoen-Klinikum 18
B. Braun Singapore Completes Acquisition Of Majority Stake In Ahlcon Parenterals For US$48 Million 19
B. Braun Melsungen Acquires 5% Stake In Rhoen-Klinikum 21
B. Braun Melsungen Acquires Nutrichem diat+pharma From SSP 22
B. Braun Melsungen AG – Key Competitors 23
B. Braun Melsungen AG – Key Employees 24
B. Braun Melsungen AG – Locations And Subsidiaries 25
Head Office 25
Other Locations & Subsidiaries 25
Joint Venture 29
Recent Developments 31
Strategy And Business Planning 31
Dec 12, 2017: B. Braun establishes a subsidiary in Zambia 31
Jul 28, 2017: Indonesian Minister of Health Launches New German Pharmaceutical Factory in Karawang 32
Financial Announcements 33
Mar 31, 2017: B. Braun continues its sales and earnings growth 33
Mar 23, 2016: B. Braun’s growth trend continues 35
Corporate Communications 37
Jul 31, 2017: Dr. Joachim Schulz joins the Management Board of B. Braun Melsungen 37
Apr 12, 2017: Change in the B. Braun Management Board and the Aesculap Management Board 38
Feb 22, 2017: Change in the B. Braun Management Board 39
Oct 05, 2016: B. Braun Supports The International Safety Center 40
Other Significant Developments 41
Jun 08, 2017: B. Braun is participating in the third edition of the High-Tech Founders Fund 41
Feb 15, 2017: B. Braun Medical to Present Comprehensive Parenteral Nutrition Program at ASPEN’s Clinical Nutrition Week 42
Appendix 43
Methodology 43
About GlobalData 43
Contact Us 43
Disclaimer 43

List of Tables
B. Braun Melsungen AG, Pharmaceuticals & Healthcare, Key Facts, 2016 2
B. Braun Melsungen AG, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
B. Braun Melsungen AG, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
B. Braun Melsungen AG, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
B. Braun Melsungen AG, Deals By Therapy Area, 2011 to YTD 2017 8
B. Braun Melsungen AG, Medical Devices Deals, 2011 to YTD 2017 9
B. Braun Melsungen AG, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 10
B. Braun Enters into Parntership with Royal Philip 11
Proxy Biomedical Extends Distribution Agreement with B. Braun Surgical 12
Kinetic Concepts Enters into Co-Marketing Agreement with B. Braun Medical for Prontosan 13
Yungjin Enters Into Distribution Agreement With B. Braun For Enteral Nutrition Products 14
B. Braun Medical Acquires Dismed Pharma and Dismed Criticare 15
B. Braun Medical Acquires Carenalis 16
B. Braun Avitum Acquires 51% Stake in Dialy Ser 17
B. Braun Melsungen Completes Acquisition Of Additional 3.02% Stake In Rhoen-Klinikum 18
B. Braun Singapore Completes Acquisition Of Majority Stake In Ahlcon Parenterals For US$48 Million 19
B. Braun Melsungen Acquires 5% Stake In Rhoen-Klinikum 21
B. Braun Melsungen Acquires Nutrichem diat+pharma From SSP 22
B. Braun Melsungen AG, Key Competitors 23
B. Braun Melsungen AG, Key Employees 24
B. Braun Melsungen AG, Other Locations 25
B. Braun Melsungen AG, Subsidiaries 25
B. Braun Melsungen AG, Joint Venture 29

★海外企業調査レポート[B. Braun Melsungen AG-製薬・医療分野:企業M&A・提携分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • 3i Group Plc:企業のM&A・事業提携・投資動向
    3i Group Plc - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's 3i Group Plc Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestments, …
  • Tata Steel Group:企業の戦略・SWOT・財務情報
    Tata Steel Group - Strategy, SWOT and Corporate Finance Report Summary Tata Steel Group - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and cor …
  • Sealed Air Corporation:企業の戦略・SWOT・財務情報
    Sealed Air Corporation - Strategy, SWOT and Corporate Finance Report Summary Sealed Air Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offer …
  • Nanolek:製薬・医療:M&Aディール及び事業提携情報
    Summary Nanolek is a drug development company that offers production of import-substituting and novel pharmaceuticals. The company’s product portfolio includes vaccines, drugs for treatment of leukemias, breast cancer, brain cancer, stomach and ovarian cancer, colorectal cancer, HIV infection and ot …
  • Bio-Path Holdings Inc (BPTH):企業の財務・戦略的SWOT分析
    Summary Bio-Path Holdings Inc (Bio-Path) is a clinical stage biotechnology company that develops targeted therapies for acute myeloid leukemia (AML), chronic myeloid leukemia (CML) and other challenging cancers. The company provides products pipeline such as prexigebersen (Liposomal Grb2 Antisense) …
  • National Aerospace Fasteners Corporation:企業の戦略・SWOT・財務情報
    National Aerospace Fasteners Corporation - Strategy, SWOT and Corporate Finance Report Summary National Aerospace Fasteners Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT …
  • Icon Energy Ltd (ICN):企業の財務・戦略的SWOT分析
    Summary Icon Energy Ltd (Icon Energy), formerly Icon Oil NL, is an oil and gas exploration and production company that acquires, explores, and develops oil and gas properties. The company's exploration tenements include ATP 855, PRL's 33-49, ATP 594, ATP 626, ATP 794, ATP 549 West, PEP 170, PEP 172, …
  • Doutor Coffee Co. Ltd.
    Doutor Coffee Co. Ltd. - Strategy, SWOT and Corporate Finance Report Summary Doutor Coffee Co. Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offer …
  • Zuivelcooperatie FrieslandCampina UA:企業の戦略的SWOT分析
    Zuivelcooperatie FrieslandCampina UA - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and majo …
  • Laboratory Corp of America Holdings (LH)-製薬・医療分野:企業M&A・提携分析
    Summary Laboratory Corp of America Holdings (LabCorp) is a provider of clinical laboratory services and end-to-end drug development support. It focuses on the development and commercialization of a wide range of diagnostic technologies and testing services. The company offers clinical diagnostics la …
  • Unibail-Rodamco-Westfield Se
    Unibail-Rodamco-Westfield Se - Strategy, SWOT and Corporate Finance Report Summary Unibail-Rodamco-Westfield Se - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and s …
  • Partner Reinsurance Asia Pte. Ltd.
    Partner Reinsurance Asia Pte. Ltd. - Strategy, SWOT and Corporate Finance Report Summary Partner Reinsurance Asia Pte. Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, p …
  • EpiVax Inc:企業の戦略的SWOT分析
    EpiVax Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services. T …
  • Latecoere S.A.:企業の戦略・SWOT・財務情報
    Latecoere S.A. - Strategy, SWOT and Corporate Finance Report Summary Latecoere S.A. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpora …
  • Sa Sa International Holdings Limited (178):企業の財務・戦略的SWOT分析
    Sa Sa International Holdings Limited (178) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengt …
  • Volga Gas plc (VGAS):企業の財務・戦略的SWOT分析
    Summary Volga Gas Plc (Volga Gas) is an oil and gas company that provides oil and gas exploration and production services. The company acquires, produces and develops oil, natural gas deposit properties, and others. It owns and operates oil and gas producing assets in Karpenskiy licence area, Pre-Ca …
  • Premier Oil Plc (PMO):石油・ガス:M&Aディール及び事業提携情報
    Summary Premier Oil Plc (Premier Oil) is an independent upstream oil and gas company. It explores for, develops and produces crude oil and natural gas. The company has interests in the North Sea, South East Asia, Pakistan, the Falkland Islands and Latin America. It explores under-explored proven hyd …
  • Hypera SA:企業の戦略・SWOT・財務情報
    Hypera SA - Strategy, SWOT and Corporate Finance Report Summary Hypera SA - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions …
  • Fresenius Kidney Care-医療機器分野:企業M&A・提携分析
    Summary Fresenius Kidney Care (FMCNA) , formerly Fresenius Medical Care Holdings Inc, a subsidiary of Fresenius Medical Care AG & Co KGaA, is a provider of dialysis services and renal care products. The company’s dialysis products include hemodialysis; dialyzers, haemodialysis machines, FMiS medical …
  • Abraxas Petroleum Corp (AXAS):企業の財務・戦略的SWOT分析
    Summary Abraxas Petroleum Corp (Abraxas) operates as an oil and gas company. The company offers exploration, production and development of oil and gas properties across the US. Its properties are located in Mid-Continent, Rocky Mountain, Gulf Coast and Permian Basin regions of the US. Abraxas’s Perm …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆